For example, a combination of PI3K inhibitors and pan-SHIP1/2 inhibitors could lower the concentration of both PI(3,4,5)P3 and P(3,4)P2 on the cell membrane leading to the death of the cancer cells addicted to the AKT signaling cascade. This evidence concerns the gene AKT1 and cancer.